GSK puts 19 brands up for sale

GLOBAL - GlaxoSmithKline has announced plans to sell off 19 brands from its non-core over the counter business in order to focus on its "priority brands" in the Consumer Healthcare business.

Gastro-intestinal drug Zantac is among the 19 brands.
Gastro-intestinal drug Zantac is among the 19 brands.

GSK will sell a range of brands with sales of more than US$8 million per annum, including Nytol and FiberChoice, a dietary supplement.

GSK has said that certain brands have "lacked focus" due to other global priorities and says that other companies would be able to "maximise the potential they offer".

GSK plans to focus its Consumer Healthcare business on the oral health, wellness (OTC) and nutrition categories, which includes brands Sensodyne, Panadol and Horlicks.

GSK aims for the re-focused business to lead the market in the smoking control, denture care, dental sensitivity, analgesics and nutrition categories.

Andrew Witty, chief executive of GSK, said, "Consumer Healthcare is a key growth driver for GSK.  But it is important that we focus this business around product categories, brands and markets where we have most depth and competitive advantage, with the best prospects for strong growth.

"This divestment is also an example of our commitment to focus on realising value and enhancing returns to shareholders."

The 19 brands planned to be divested by the end of the year, are:

  • Abtei, vitamins, minerals and supplements
  • Alli, weight management
  • Beano, gastro-intestinal
  • BC, analgesic
  • Beconase, respiratory
  • Debrox, ear wax cleanser
  • Dequadin, cough/cold
  • Ecotrin, analgesics
  • FiberChoice, dietary supplement
  • Goody’s, analgesics
  • Granufink, urological
  • Lactacyd, feminine hygiene
  • Libenar, respiratory
  • Nytol, sleep aid
  • Phillips MOM, gastro-intestinal
  • Solpadeine, analgesics
  • Tagamet/Stomedine, gastro-intestinal
  • Valda, cough/cold supplement
  • Zantac OTC, gastro-intestinal

This article was first published on marketingmagazine.co.uk

Source:
Campaign Asia
Tags

Related Articles

Just Published

1 hour ago

US regulator asks Omnicom and IPG for information ...

Shareholder vote due to take place on 18 March.

2 hours ago

'Not every brand or company needs to build AI': ...

Amidst the AI gold rush, Google's Southeast Asia VP offers CMOs practical wisdom: Demonstrate value from existing tools before seeking new budgets, invest in prompt engineering expertise, and remember that while technology evolves rapidly, authenticity remains the currency that no algorithm can mint.

3 hours ago

AFL invites a younger generation to the world of ...

72andSunny and the AFL celebrate football fandom in Australia while trying to woo a younger audience.

3 hours ago

Beyond keywords: Unlocking the power of AI ...

As digital marketing shifts, brands must pivot from search engine optimisation to influencing AI systems like ChatGPT and Google Gemini, which now shape consumer perceptions, says Alfonso Asensio, MD of Jellyfish Japan.